WO2009105786A3 - Treatment for oral disease - Google Patents

Treatment for oral disease Download PDF

Info

Publication number
WO2009105786A3
WO2009105786A3 PCT/US2009/034930 US2009034930W WO2009105786A3 WO 2009105786 A3 WO2009105786 A3 WO 2009105786A3 US 2009034930 W US2009034930 W US 2009034930W WO 2009105786 A3 WO2009105786 A3 WO 2009105786A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
oral disease
colonization
diseases
compositions
Prior art date
Application number
PCT/US2009/034930
Other languages
French (fr)
Other versions
WO2009105786A2 (en
Inventor
Payam Benyamini
Daniel Nazarian
Original Assignee
Periovax, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Periovax, Inc. filed Critical Periovax, Inc.
Publication of WO2009105786A2 publication Critical patent/WO2009105786A2/en
Publication of WO2009105786A3 publication Critical patent/WO2009105786A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention relates to compositions and methods for the treatment of diseases and disorders characterized by a colonization of the oral cavity by harmful bacteria, e.g., periodontal disease.
PCT/US2009/034930 2008-02-21 2009-02-23 Treatment for oral disease WO2009105786A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3048808P 2008-02-21 2008-02-21
US61/030,488 2008-02-21

Publications (2)

Publication Number Publication Date
WO2009105786A2 WO2009105786A2 (en) 2009-08-27
WO2009105786A3 true WO2009105786A3 (en) 2009-10-29

Family

ID=40986263

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/034930 WO2009105786A2 (en) 2008-02-21 2009-02-23 Treatment for oral disease

Country Status (1)

Country Link
WO (1) WO2009105786A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101038126B1 (en) 2010-11-30 2011-05-31 주식회사 엘지생명과학 Novel hybrid promoter and recombinant vector which includes the promoter
US9110030B2 (en) 2012-06-29 2015-08-18 Daniel A. Kerschensteiner Colorimetric gelatinase assay
CN105611909B (en) 2013-03-12 2020-09-15 普莱玛疗法公司 Dental compositions comprising chelating agents and bases
CN110357971B (en) * 2019-08-21 2021-01-15 中国科学院微生物研究所 Pig compound interferon for emergency prevention of African swine fever

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KING A.E. ET AL.: "Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells", MOLECULAR HUMAN REPRODUCTION, vol. 8, no. 4, 2002, pages 341 - 349 *
MATHEWS M. ET AL.: "Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands", INFECT IMMUN., vol. 67, no. 6, June 1999 (1999-06-01), pages 2740 - 2745, XP002255626 *
TAO R. ET AL.: "Salivary Antimicrobial Peptide Expression and Dental Caries Experience in Children", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 49, no. 9, September 2005 (2005-09-01), pages 3883 - 3888 *
WEINBERG A. ET AL.: "Epithelial antimicrobial peptides: review and significance for oral applications", CRIT REV ORAL BIOL MED., vol. 9, no. 4, 1998, pages 399 - 414 *
YIN C. ET AL.: "Mouse salivary glands and human 13 -defensin-2 as a study model for antimicrobial gene therapy: technical considerations", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 28, no. 4, October 2006 (2006-10-01), pages 352 - 360, XP005661778 *

Also Published As

Publication number Publication date
WO2009105786A2 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
EP2371347A3 (en) Oral care compositions
IL253038A0 (en) Compositions and methods for the treatment of the prevention oral infections by e. coli
WO2009126688A3 (en) Novel compositions and methods for the treatment of immune related diseases
EP1876990A4 (en) Treatment of teeth by aligners
WO2013072932A3 (en) Oral care compositions
WO2008113469A8 (en) Substituted imidazopyrimidines and triazolopyrimidines
EP2415749A4 (en) New salvianolic acid compound l, preparation method and use thereof
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2007142755A3 (en) Purine analogs
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2010009127A3 (en) Tooth whitening compositions and methods
WO2008155069A3 (en) Substituted oxazolidinones and use thereof
MY158777A (en) Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
IL195986A0 (en) Herbal compositions for the treatment of diseases of the oral cavity
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
PL2328417T3 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF beta-AMYLOID DISEASES AND SYNUCLEINOPATHIES
WO2011100671A3 (en) Methods and compositions to improve mechanical resistance of teeth
WO2009074247A8 (en) Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
WO2009138843A9 (en) Glycosaminoglycan oral use and compositions
WO2011069032A3 (en) Formulations, salts and polymorphs of transnorsertraline and uses thereof
WO2009105786A3 (en) Treatment for oral disease
WO2008112840A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2010121213A3 (en) Antibacterial compositions
IL194353A0 (en) Lysobactin amides
HU0500145D0 (en) Composition for the treatment of oral diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09711842

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09711842

Country of ref document: EP

Kind code of ref document: A2